2014-03-29 HistoSonics Inc. Vortx Rx®

CMX Research Inc. is pleased to be supporting the HistoSonics, Inc. trial involving the Vortx RX ® to treat Benign Prostatic Hyperplasia (BPH). The Vortx RX® is a portable ultrasound therapy device that is intended for the treatment of BPH by using very intense, low duty-cycle ultrasound pulses. (The Vortx RX is an investigational device and is limited by law to investigational use by qualified investigators in the U.S. and Canada.)